Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Feb 23;17(1):329-336.
doi: 10.1159/000536458. eCollection 2024 Jan-Dec.

Acquired Angioedema Associated with Lymphoproliferative Disorders

Jun Yen Ng  1 , Meidelynn Ooi  1 , Samuel K Bennett  1 , Kirsty Rady  1 , Philip Choi  1 , Wei-I Lee  2 , Matthew C Cook  2   3   4 , Katrina L Randall  2   5 , Nalini K Pati  1
Affiliations
Case Reports

Acquired Angioedema Associated with Lymphoproliferative Disorders

Jun Yen Ng et al. Case Rep Oncol. .

Abstract

Introduction: Acquired angioedema due to C1 esterase inhibitor deficiency (C1INH-AAE) is most associated with lymphoproliferative disorders (LPDs), particularly low-grade B-cell subtypes. The condition remains under-recognized with long diagnostic delays due to various challenges including a lack of awareness of the condition.

Case presentation: We discuss 4 cases of C1INH-AAE associated with low-grade B-cell LPDs, including various diagnostic and management challenges. As our cases illustrate, constitutional symptoms or overt manifestations of LPD at diagnosis are often absent. Hence, a comprehensive multimodal approach to screening for an underlying B-LPD is important when a diagnosis of acquired angioedema is made. Levels of complement C4, C1q, and C1INH are useful for diagnosing C1INH-AAE and for monitoring disease activity. Changes in these parameters may also indicate relapse of the underlying hematological malignancy. Treating the underlying disorder is important as this commonly leads to clinical improvement with decreased episodes of angioedema and normalization of complement studies.

Conclusion: Awareness of C1INH-AAE can lead to an early diagnosis of hematological malignancies. The absence of constitutional symptoms emphasizes the need for a comprehensive multimodal approach to screening for LPD in C1INH-AAE. C4, C1INH level, and function are useful for monitoring disease activity.

Keywords: B-lymphoproliferative disorder; Complement; Diagnostic challenge; Splenic marginal zone lymphoma.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

    1. Zanichelli A, Azin GM, Wu MA, Suffritti C, Maggioni L, Caccia S, et al. . Diagnosis, course, and management of angioedema in patients with acquired C1-inhibitor deficiency. J Allergy Clin Immunol Pract. 2017;5(5):1307–13. - PubMed
    1. Cicardi M, Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol. 2010;6(1):14. - PMC - PubMed
    1. Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol. 2003;3(3):311–7. - PubMed
    1. Shi Y, Wang C. Where we are with acquired angioedema due to C1 inhibitor deficiency: a systematic literature review. Clin Immunol. 2021;230:108819. - PubMed
    1. Bekos C, Perkmann T, Krauth M, Raderer M, Lechner K, Jaeger U. Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment. Leuk Lymphoma. 2016;57(9):2033–6. - PubMed

Publication types